The newly identified antibody was isolated using lymphocytes from COVID-19 patients enrolled in the ImmunoCoV study being carried out by CHUV’s Service of Immunology and Allergy. This antibody is one of the most powerful identified so far against SARS-CoV-2. Structural characterization of the antibody indicates that it binds to an area that is not subjected to mutations of the spike protein.
Scientists discover a highly potent antibody against SARS-CoV-2
October 12, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022